Hologic Announces Third Quarter Fiscal 2008 Operati...(withthat acquisition we anticipate that ...),Health

Date:7/30/2008

with that acquisition we anticipate that we will incur significant charges in the fourth quarter, including costs associated with the write-off of in-process research and development, the increase in amortization of intangible assets, and the increase in costs of products sold associated with the write-up of Third Wave inventory to fair value. We have not yet determined the amount of these increases as we are currently in the process of valuing the underlying assets. We expect other charges associated with the inclusion of Third Wave results during the quarter, including interest expense of approximately $7.0 million, to be approximately $0.03 dilutive.

-- Including the dilutive effect of Third Wave, Hologic expects fiscal 2008 non-GAAP adjusted earnings of approximately $1.18 per diluted share, compared with previous guidance of $1.15 - $1.18 per diluted share without the acquisition of Third Wave.

The Company recently completed a two-for-one stock split, effected in the form of a stock dividend with a record date of March 21, 2008 and a payment date of April 2, 2008. The Company's financial information in this press release and the financial statements to be included in its Quarterly Report on Form 10-Q for its quarter and nine months ended June 28, 2008 will retroactively reflect the stock split.

Hologic's management will host a conference call on Thursday, July 31, 2008 at 9:00 a.m. (Eastern) to discuss third quarter fiscal 2008 operating results. Interested participants may listen to the call by dialing 877-874-1589 or 719-325-4839 for international callers and referencing code 8448474 approximately 15 minutes prior to the call. For those unable to participate in the live broadcast, a replay will be available one hour after the call ends through August 8, 2008 at 888-203-1112 or 719-457-0820 for international callers, access code 8448474. The Company will also provide a live webcast of the call on the investor relations page of the Company
'/>"/>

SOURCE Hologic, Inc. Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
Related medicine news :

1. Psychological downside to strike action
2. Psychological and Social Issues Associated With Tooth Loss
3. Psychological and social issues associated with tooth loss
4. Hologic, Inc. Announces Grant of Early Termination of Antitrust Waiting Period for Third Wave Technologies, Inc. Tender Offer
5. Hologic to Present at the Jefferies 2nd Annual Healthcare Conference
6. Hologic to Acquire Third Wave Technologies
7. Metformin increases pathologic complete response rates in breast cancer patients with diabetes
8. Hologic to Present at NASDAQs 21st Investor Program in London
9. Hologic Announces Organizational Change
10. Can pathological techniques help identify primary colorectal signet ring cell carcinoma?
11. Electric shocks can cause neurologic and neuropsychological symptoms